The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.
The Food and Drug Administration (FDA) has banned the import of genetically modified (GM) salmon until it issues the product labelling guidelines.
In Alaska, many politicians have reiterated their opposition to GM salmon marketing as fishermen’s wild caught sockeye will have to compete with genetically manipulated fish that grows at twice the rate of wild salmon.
. . . .
Last November, the FDA had given green light to AquaBounty Technologies Inc. to start marketing its AquAdvantage salmon.
This new restriction of the agency follows a bill that became law on 18 December by which FDA must issue the new guidelines before the fish can be sold.
Chief Executive Officer of the biotechnology company, Ronald Stotish, minimized the impact of the action taken by the FDA: “The decision has no impact on AquaBounty’s operations as we are not currently importing our salmon into the U.S.”
“The fish are grown in tanks at facilities in Canada and Panama,” the executive noted.
Under the import ban, all shipments suspected to contain GE salmon are to be held and forwarded to the local FDA District Compliance Branch, Regulatory Focus informed.
The measure will be in force during 2016.
Read full, original post: FDA vetoes GM salmon import
